• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Transient rise in CA 125 in a woman with ovarian carcinoma and COVID-19 infection.

作者信息

Smith Maria, Lara Olivia D, Pothuri Bhavana

机构信息

New York University Grossman School of Medicine, New York, NY, United States.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Perlmutter Cancer Center, NYU Langone Health, New York, NY, United States.

出版信息

Gynecol Oncol Rep. 2020 Nov;34:100644. doi: 10.1016/j.gore.2020.100644. Epub 2020 Sep 17.

DOI:10.1016/j.gore.2020.100644
PMID:32964093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7497776/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d4/7509775/5da3cdb97110/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d4/7509775/5da3cdb97110/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d4/7509775/5da3cdb97110/gr1.jpg

相似文献

1
Transient rise in CA 125 in a woman with ovarian carcinoma and COVID-19 infection.一名患有卵巢癌且感染新冠病毒的女性患者CA 125水平短暂升高。
Gynecol Oncol Rep. 2020 Nov;34:100644. doi: 10.1016/j.gore.2020.100644. Epub 2020 Sep 17.
2
Significance of some tumor markers in differential diagnosis of ovarian tumor.某些肿瘤标志物在卵巢肿瘤鉴别诊断中的意义
Rocz Akad Med Bialymst. 1999;44:235-43.
3
Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
Gynecol Obstet Invest. 1987;23(3):200-7. doi: 10.1159/000298862.
4
Rupture of an endometrioma with extremely high serum CA-125 level (> 10,000 IU/ml) and ascites resembling ovarian cancer.子宫内膜异位囊肿破裂，血清CA - 125水平极高（>10,000 IU/ml），且腹水类似卵巢癌。
Eur J Gynaecol Oncol. 2014;35(4):469-72.
5
Serum copper in ovarian carcinoma.
Cancer. 1988 Mar 1;61(5):1015-7. doi: 10.1002/1097-0142(19880301)61:5<1015::aid-cncr2820610526>3.0.co;2-t.
6
Clear cell ovarian carcinoma in a pregnant woman with a history of infertility, endometriosis and unsuccessful IVF treatment.一名有不孕症、子宫内膜异位症病史且体外受精治疗失败的孕妇患透明细胞卵巢癌。
Eur J Gynaecol Oncol. 2003;24(5):438-41.
7
Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma.上皮性卵巢癌患者术前血清CA-125水平与生存的关系。
J Reprod Med. 1996 Mar;41(3):140-2.
8
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology.
Eur J Gynaecol Oncol. 1990;11(2):111-5.
9
[The value of CA 125 determination in the serum of patients with ovarian cancer].
Zentralbl Gynakol. 1989;111(5):301-9.
10
Peritoneal tuberculosis mimicking ovarian carcinoma with ascites and elevated serum CA-125: case report and review of literature.表现为伴有腹水和血清CA - 125升高的卵巢癌的腹膜结核：病例报告及文献复习
Eur J Gynaecol Oncol. 2002;23(2):120-2.

引用本文的文献

1
Rising CA-125 (Cancer Antigen 125) Levels: Cancer Recurrence or a Vaccine Reaction?癌抗原125（CA - 125）水平升高：癌症复发还是疫苗反应？
Cureus. 2023 Feb 2;15(2):e34534. doi: 10.7759/cureus.34534. eCollection 2023 Feb.
2
Surveillance of gynecologic cancer patients post-COVID-19 vaccine: Are CA-125 levels reliable?新冠疫苗接种后妇科癌症患者的监测：癌抗原125（CA-125）水平可靠吗？
Gynecol Oncol Rep. 2023 Feb;45:101140. doi: 10.1016/j.gore.2023.101140. Epub 2023 Jan 21.
3
CA-125 monitoring in gynecologic cancer patients with COVID-19: A case series.

本文引用的文献

1
Potential influence of COVID-19/ACE2 on the female reproductive system.新型冠状病毒肺炎/血管紧张素转换酶 2 对女性生殖系统的潜在影响。
Mol Hum Reprod. 2020 Jun 1;26(6):367-373. doi: 10.1093/molehr/gaaa030.
2
Elevations of serum cancer biomarkers correlate with severity of COVID-19.血清癌症生物标志物的升高与 COVID-19 的严重程度相关。
J Med Virol. 2020 Oct;92(10):2036-2041. doi: 10.1002/jmv.25957. Epub 2020 Jun 3.
3
Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective.上皮性卵巢癌诊断中的循环生物标志物：从现状到未来展望
Gynecol Oncol Rep. 2022 Jun 17;42:101029. doi: 10.1016/j.gore.2022.101029. eCollection 2022 Aug.
4
Tumor marker response to SARS-CoV-2 infection among patients with cancer.癌症患者对 SARS-CoV-2 感染的肿瘤标志物反应。
Cancer Med. 2022 Jul;11(14):2865-2872. doi: 10.1002/cam4.4646. Epub 2022 Mar 15.
5
Effect of the coronavirus pandemic on tumor markers.冠状病毒大流行对肿瘤标志物的影响。
J Med Virol. 2021 Sep;93(9):5405-5408. doi: 10.1002/jmv.27057. Epub 2021 Jun 12.
Ann Transl Med. 2017 Jul;5(13):276. doi: 10.21037/atm.2017.05.13.
4
Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.慢性阻塞性肺疾病（COPD）急性加重期肿瘤标志物与炎症生物标志物的比较。
Scand J Clin Lab Invest. 2015 Apr;75(2):126-32. doi: 10.3109/00365513.2014.992944. Epub 2015 Jan 19.
5
Serum CA-125: biomarker of pulmonary tuberculosis activity and evaluation of response to treatment.血清癌抗原125：肺结核活动的生物标志物及治疗反应评估
Clin Invest Med. 2012 Aug 4;35(4):E223-8.
6
The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.在前列腺、肺癌、结直肠癌和卵巢癌（PLCO）筛查试验中，无卵巢癌证据的女性CA-125的流行病学情况。
Gynecol Oncol. 2008 Sep;110(3):383-9. doi: 10.1016/j.ygyno.2008.05.006. Epub 2008 Jun 30.
7
Benign causes of increased serum CA-125 concentration.
Lancet Oncol. 2007 Dec;8(12):1054-1055. doi: 10.1016/S1470-2045(07)70357-1.
8
Pelvic inflammatory disease. Correlation of severity with CA-125 levels.
J Reprod Med. 1996 May;41(5):341-6.
9
What do we know about the origin of CA 125?我们对CA 125的起源了解多少？
Eur J Obstet Gynecol Reprod Biol. 1993 Apr;49(1-2):93-8. doi: 10.1016/0028-2243(93)90131-u.
10
CA 125 secretion by peritoneal mesothelial cells.腹膜间皮细胞分泌CA 125
J Clin Pathol. 1994 Mar;47(3):263-5. doi: 10.1136/jcp.47.3.263.